NCT04686227

Brief Summary

Uterine malformation is occur due to the abnormal development of Mullerian canal during embryogenesis and it is known that it reduces the fertility and live birth rate and also increases the abortion and preterm birth rate. There are different classification methods have been used for defining the uterine malformations. The most common used classification method in the World is American Society of Reproductive Medicine (ASRM)'s system. In addition European Society of Human Reproduction and Embryology (ESHRE) and European Society for Gynaecological Endoscopy (ESGE) developed a new classification system. ASRM Uterine malformation Classification which is used for diagnosis and treatment of uterine malformations in our clinic is subdivided into 7 titles:

  1. 1.Agenesis or Hypoplasia -(a. Vaginal b. Cervical c. Fundal d. Tubal e. Combine)
  2. 2.Unicornuate -(a. Communicating Horn b. Non-Communicating Horn c. No Cavity d. No Horn)
  3. 3.Uterus Didelphus
  4. 4.Bicornuate Uterus-(a. Complete b. Partial)
  5. 5.Uterine Septum- (a. Complete b. Partial)
  6. 6.Arcuate Uterus
  7. 7.Diethylstilboestrol (DES) Related

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 18, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 28, 2020

Completed
2 years until next milestone

Study Start

First participant enrolled

January 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

March 17, 2022

Status Verified

March 1, 2022

Enrollment Period

1 year

First QC Date

December 18, 2020

Last Update Submit

March 15, 2022

Conditions

Keywords

Uterine MalformationsFertilityInfertilityPregnancyMiscarriage

Outcome Measures

Primary Outcomes (5)

  • Prevalence of uterine malformations

    prevalence of uterine malformations in study population according to ASRM/ESHRE classifications

    1 year after inclusion of last participant

  • spontaneous fecundability

    1 year fecundability rate in subgroup of malformations and normal uterus

    1 year after inclusion of last participant

  • Pregnancy outcomes

    Rate of miscarriage, preterm birth, and malpresentation

    During the pregnancy

  • Live birth rate

    Having a live birth in all subgroups of uterine malformations and normal uterus

    1 year

  • comparing of infertility rates

    comparing of infertility rates between normal uterus population and every subgroup of uterine malformations

    1 year

Study Arms (2)

Group-1, women with normal uterus

Diagnostic Test: 3D Ultrasound

Group-2, women with any uterine malformations

Group-2 is going to be sub-grouped according to ASRM and ESHRE classifications

Diagnostic Test: 3D Ultrasound

Interventions

3D UltrasoundDIAGNOSTIC_TEST

Newly married women between the ages of 18-40 will be evaluated by 3D ultrasonography about the uterine morphology

Group-1, women with normal uterusGroup-2, women with any uterine malformations

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Newly married women between the ages of 18-40

You may qualify if:

  • Husband is under 45 years old

You may not qualify if:

  • Azospermia
  • Women with Premature Ovarian Failure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe UniversityHacettepe University School of Medicine, Department of Ob/Gyn

Ankara, 06100, Turkey (Türkiye)

Location

Related Publications (6)

  • Chan YY, Jayaprakasan K, Tan A, Thornton JG, Coomarasamy A, Raine-Fenning NJ. Reproductive outcomes in women with congenital uterine anomalies: a systematic review. Ultrasound Obstet Gynecol. 2011 Oct;38(4):371-82. doi: 10.1002/uog.10056.

    PMID: 21830244BACKGROUND
  • Raga F, Bauset C, Remohi J, Bonilla-Musoles F, Simon C, Pellicer A. Reproductive impact of congenital Mullerian anomalies. Hum Reprod. 1997 Oct;12(10):2277-81. doi: 10.1093/humrep/12.10.2277.

    PMID: 9402295BACKGROUND
  • Rackow BW, Arici A. Reproductive performance of women with mullerian anomalies. Curr Opin Obstet Gynecol. 2007 Jun;19(3):229-37. doi: 10.1097/GCO.0b013e32814b0649.

    PMID: 17495638BACKGROUND
  • Tomazevic T, Ban-Frangez H, Ribic-Pucelj M, Premru-Srsen T, Verdenik I. Small uterine septum is an important risk variable for preterm birth. Eur J Obstet Gynecol Reprod Biol. 2007 Dec;135(2):154-7. doi: 10.1016/j.ejogrb.2006.12.001. Epub 2006 Dec 19.

    PMID: 17182166BACKGROUND
  • Graupera B, Pascual MA, Hereter L, Browne JL, Ubeda B, Rodriguez I, Pedrero C. Accuracy of three-dimensional ultrasound compared with magnetic resonance imaging in diagnosis of Mullerian duct anomalies using ESHRE-ESGE consensus on the classification of congenital anomalies of the female genital tract. Ultrasound Obstet Gynecol. 2015 Nov;46(5):616-22. doi: 10.1002/uog.14825. Epub 2015 Oct 5.

    PMID: 25690307BACKGROUND
  • Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org; Practice Committee of the American Society for Reproductive Medicine. Uterine septum: a guideline. Fertil Steril. 2016 Sep 1;106(3):530-40. doi: 10.1016/j.fertnstert.2016.05.014. Epub 2016 May 25.

    PMID: 27235766BACKGROUND

MeSH Terms

Conditions

InfertilityUterine AnomaliesAbortion, Spontaneous

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy Complications

Study Officials

  • Sezcan Mumusoglu, Assoc. Prof.

    Hacettepe University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sezcan Mumusoglu, Assoc. Prof.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 18, 2020

First Posted

December 28, 2020

Study Start

January 1, 2023

Primary Completion

January 1, 2024

Study Completion

December 1, 2024

Last Updated

March 17, 2022

Record last verified: 2022-03

Locations